{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:11Z","timestamp":1791237971571,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","award":["DT\/2018\/0054"],"award-info":[{"award-number":["DT\/2018\/0054"]}],"id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001635","name":"University of Limerick","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001588","name":"Enterprise Ireland","doi-asserted-by":"publisher","award":["DT\/2018\/0054"],"award-info":[{"award-number":["DT\/2018\/0054"]}],"id":[{"id":"10.13039\/501100001588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tice.2026.103600","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:27:34Z","timestamp":1778480854000},"page":"103600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Potential of a bacterial immunomodulatory enzyme to restore health in a Th17 cytokine cocktail-induced skin psoriasis model"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-8516","authenticated-orcid":false,"given":"Promita","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayakumar","family":"Gedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratikkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"McGourty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103600_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621956","article-title":"Major role of the IL17\/23 axis in psoriasis supports the development of new targeted therapies","volume":"12","author":"Bugaut","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.tice.2026.103600_bib2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1189\/jlb.0212101","article-title":"Targeting the Th17 pathway in psoriasis","volume":"92","author":"Elloso","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.tice.2026.103600_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tice.2026.103600_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11596-007-0329-1","article-title":"Expression of Th17 cytokines in skin lesions of patients with psoriasis","volume":"27","author":"Li","year":"2007","journal-title":"J. Huazhong Univ. Sci. Technol."},{"issue":"5","key":"10.1016\/j.tice.2026.103600_bib5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.tice.2026.103600_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.tice.2026.103600_bib7","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.tice.2026.103600_bib8","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.4049\/jimmunol.180.11.7423","article-title":"Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes","volume":"180","author":"P\u00e8ne","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.tice.2026.103600_bib9","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.tice.2026.103600_bib10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.tice.2026.103600_bib11","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3\u03b1\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.tice.2026.103600_bib12","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1073\/pnas.82.23.8144","article-title":"Mechanism of action of the group A streptococcal C5a inactivator","volume":"82","author":"Wexler","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.tice.2026.103600_bib13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/iai.60.12.5219-5223.1992","article-title":"Streptococcal C5a peptidase is a highly specific endopeptidase","volume":"60","author":"Cleary","year":"1992","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.tice.2026.103600_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/iai.64.2.503-510.1996","article-title":"C5a peptidase alters clearance and trafficking of group A streptococci by infected mice","volume":"64","author":"Ji","year":"1996","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.tice.2026.103600_bib15","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/IAI.66.11.5399-5405.1998","article-title":"Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes","volume":"66","author":"Ji","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.tice.2026.103600_bib16","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.csbj.2021.04.024","article-title":"Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease","volume":"19","author":"Te\u00e7za","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tice.2026.103600_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156652","article-title":"C5a peptidase (ScpA) activity towards human type II and type III interferons","volume":"180","author":"Duarte","year":"2024","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.tice.2026.103600_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0733-8635(03)00126-8","article-title":"Retinoid therapy for psoriasis","volume":"22","author":"Yamauchi","year":"2004","journal-title":"Dermatol. Clin."},{"issue":"8","key":"10.1016\/j.tice.2026.103600_bib19","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1021\/acs.molpharmaceut.3c00207","article-title":"Impact of propeptide cleavage on the stability and activity of a streptococcal immunomodulatory C5a peptidase for biopharmaceutical development","volume":"20","author":"Gedi","year":"2023","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.tice.2026.103600_bib20","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.jaci.2016.09.016","article-title":"Epidermal equivalents of filaggrin null keratinocytes do not show impaired skin barrier function","volume":"139","author":"Niehues","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.tice.2026.103600_bib21","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1038\/s41598-017-12041-y","article-title":"Immortalized N\/TERT keratinocytes as an alternative cell source in 3D human epidermal models","volume":"7","author":"Smits","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103600_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156994","article-title":"Therapeutic potential of an immunomodulatory enzyme, ScpA, in interferon gamma (IFN-\u03b3) induced skin Psoriasis","volume":"194","author":"Bhattacharjee","year":"2025","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.tice.2026.103600_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.tice.2026.103600_bib24","unstructured":"Bhattacharjee, P., Gedi, V., Duarte, F., Kumar Patel, P., Hudson, S.P., & McGourty, K., Potential of a bacterial immunomodulatory enzyme to restore health in Th1 cytokine cocktail induced skin psoriasis, Immunopharmacology and Immunotoxicology (under review). n.d."},{"issue":"2","key":"10.1016\/j.tice.2026.103600_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jid.2014.495","article-title":"Assessing the in vivo epidermal barrier in mice: dye penetration assays","volume":"135","author":"Schmitz","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.tice.2026.103600_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.0022-202X.2005.23935.x","article-title":"High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis","volume":"125","author":"de Jongh","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.tice.2026.103600_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased \u03b2-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.tice.2026.103600_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12013-012-9499-y","article-title":"Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1\/2 and GSK-3\u03b2","volume":"66","author":"Chen","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.tice.2026.103600_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1523-1747.ep12391802","article-title":"Up-regulation of elafin\/SKALP gene expression in psoriatic epidermis","volume":"103","author":"Nonomura","year":"1994","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.tice.2026.103600_bib30","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.jid.2023.03.758","article-title":"749 TNF-\u03b1 promotes psoriasis-related keratinocytes dedifferentiation through dual regulation of YAP and NOTCH1 signaling","volume":"143","author":"Yu","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.tice.2026.103600_bib31","doi-asserted-by":"crossref","first-page":"18045","DOI":"10.1038\/s41598-017-18404-9","article-title":"RNA-seq identifies a diminished differentiation gene signature in primary monolayer keratinocytes grown from lesional and uninvolved psoriatic skin","volume":"7","author":"Swindell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103600_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1186455","article-title":"Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies","volume":"14","author":"Brembilla","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103600_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125244","article-title":"An in-situ forming controlled release soft hydrogel-based C5a peptidase drug delivery system to treat psoriasis","volume":"671","author":"Patel","year":"2025","journal-title":"Int. J. Pharm."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626002934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626002934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:18:55Z","timestamp":1784067535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626002934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0040816626002934"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103600","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of a bacterial immunomodulatory enzyme to restore health in a Th17 cytokine cocktail-induced skin psoriasis model","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103600"}}